Reviews of Clinical IssueThe Use of Probiotic Saccharomyces boulardii for Diarrhea ManagementLaski, Laura C. RD, LDN, CNSDAuthor Information University of Maryland Medical Center, Baltimore, and University of Medicine and Dentistry of New Jersey, Newark. Corresponding Author: Laura C. Laski, RD, LDN, CNSD, Department of clinical nutrition SGD-12B, University of Maryland Medical Center, 22 South Green Street, Baltimore, MD 21201 (email@example.com). We thank Dr. Diane Rigassio Radler at University of Medicine and Dentistry of New Jersey for her assistance with this article. Topics in Clinical Nutrition: January-March 2008 - Volume 23 - Issue 1 - p 71-75 doi: 10.1097/01.TIN.0000312082.68823.11 Buy Metrics Abstract The utilization of probiotics is growing in clinical practice for treatment of diarrhea and other malabsorptive conditions. When using probiotics patients must be treated with the strain and dose that has been used in research on the basis of the disease state. The nonpathogenic probiotic yeast Saccharomyces boulardii, given in a dose of 2g/d, shows promising results for treating antibiotic associated diarrhea and recurrent Clostridium difficile disease. Risk factors such as immunosuppression or the presence of a central venous catheter must be considered when incorporating all probiotics especially Saccharomyces boulardii. © 2008 Lippincott Williams & Wilkins, Inc.